GeoVax Labs, Inc. (GOVXW)

Market Cap	16.38M
Revenue (ttm)	6.14M
Net Income (ttm)	-24.81M
Shares Out	25.36M
EPS (ttm)	-2.29
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	113,445
Open	0.0065
Previous Close	0.0046
Day's Range	0.0035 - 0.0065
52-Week Range	0.0035 - 0.2280
Beta	3.57
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About GOVXW

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. It also developing GEO-CM04S1, a vacc...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 17
• Stock Exchange: NASDAQ
• Ticker Symbol: GOVXW
• Website: https://www.geovax.com